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Abstract 
 
Purpose: This paper investigates the possible connections between the level of chronic stress 
and success of steroid therapy in patients with sudden sensorineural hearing loss (SSNHL). 
Method: A single-center retrospective longitudinal cohort study on 55 patients in a tertiary 
referral otology center. Patients diagnosed with SSNHL between 2014 and 2017 were asked 
to complete a Measure of Perceived Stress (MPS) questionnaire. Inclusion criteria were 
patients >18 years of age, SSNHL diagnosed within 4 previous weeks, completed steroid 
treatment, and complete documentation.  
Results: There were 30 patients (55%) that showed significant improval in their pure tone 
audiogram (PTA) hearing threshold average (≥15 dB) after steroid treatment. Two-step 
cluster analysis identified three clusters based on average PTA hearing threshold recovery and 
average MPS scores. The difference between pre-treatment and post-treatment hearing levels 
was significantly higher in the cluster with moderate stress compared to clusters with mild 
and high stress levels (Kruskal-Wallis test, Friedman test, P<0.001). There were no significant 
differences in average PTA hearing threshold recovery after steroid therapy between groups 
of patients with mild and severe stress.  
Conclusions: Patients with moderate stress levels show significantly better results after steroid 
treatment for SSNHL than patients with low or high stress levels.  
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Introduction 
 
Sudden sensorineural hearing loss (SSNHL) is defined as idiopathic hearing loss greater than 
30dB on at least three contiguous hearing frequencies lasting more than three days (Merchant, 
2005). There are many theories concerning the cause of SSNHL. Most prominent are 
vascular, immune, viral, trauma and combination of these; however in most cases the real 
cause of SSNHL remains unknown (Merchant, 2005). Genetic factors may contribute to the 
SSNHL, with significant associations reported for polymorphisms in genes related to blood 
vessels, circulation, or inflammation (Capaccio, 2009, Hiramatsu, 2012). 
Many therapies have been proposed for treatment of SSNHL, but most of them were 
ultimately found to be unsuccessful (Conlin, 2007). Steroid treatment is currently regarded as 
standard therapy for SSNHL and has been used since the 1950s, although its 
pathophysiological role in hearing recovery is not completely clear. Most studies showed a 
statistically significant improvement after steroid treatment, while others did not provide 
statistical evidence that steroid treatment lead to measurable improvement (Conlin, 2007, 
Stachler, 2012). Steroid resistance is a well-known phenomenon in treatment of chronic 
inflammatory disorders like asthma and COPD (Barnes, 2013). Some studies have found that 
moderate exposure to stress increases the secretion of stress hormones and results in favorable 
physiological adaptations (Tahera, 2006, Cohen, 2007). However, stimuli that cause 
prolonged exposure to high levels of stress, may lead to under or over activation of 
physiological adaptation mechanisms, including glucocorticoid receptor expression (Schmitt, 
2000, Lopez-Gonazalez, 2009, Byl, 1984). It is not known whether steroid resistance 
contributes to the poor therapeutic response to steroid treatment in SSNHL, but there is 
considerable evidence suggesting that in response to chronic psychologic stress, key 
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physiologic systems might operate at higher or lower levels than in normal homeostasis. The 
disturbed balance of these integrated systems may translate into adverse health outcomes 
(Wright, 2009).  
Psychological stress affects the hypothalamic-pituitary adrenal axis (HPA) which is mediated 
by cortisol. The idea that stress levels may modulate steroid resistance has been already 
proposed, suggesting that stress-induced increases in glucocorticoid levels protect not against 
the source of stress itself but rather against the body's normal reactions to stress, preventing 
those reactions from overshooting and themselves threatening homeostasis (Munck, 1986). 
Endogenous glucocorticoids are released following stress-related events such as acoustic 
trauma in an effort to maintain homeostasis (Canlon, 2007). In accordance to the Arndt-
Schultz law, short term stress may benefit recovery, but prolonged periods of stress may be 
detrimental to recovery (Canlon, 2007, Arndt-Schultz, nd, Trune, 2010). Glucocorticoid 
receptors have been found in many organs including the cochlea (mostly in spiral ganglion 
cells and in smaller numbers in outer hearing cells) and they are subject to either up-
regulation or down-regulation, depending on cortisol levels in the body. Hypotheses linking 
stress associated diseases in females rely on gender-biased differences in the corticotropin-
releasing factor subtype 1 receptor (CRF1) signaling pathway (McEwen, 2007). Also, 
interactions between chronic stress and severity of chronic rhinosinuitis (CRS) have shown 
significant association between CRS severity and chronic stress levels. (Tomljenovic, 2018). 
Our hypothesis is that response to steroid therapy may be affected by the severity and duration 
of psychological stress. Early prediction of therapeutic outcome could reduce number of 
ineffective treatments and possible side effects due to administering large doses of 
corticosteroids. This paper investigates the possible connection between the level of chronic 
stress and success of steroid therapy in patients with SSNHL. 
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Patients and Methods 
 
This single-center retrospective longitudinal cohort study included patients with SSNHL 
treated with steroid therapy between 2014 and 2017 in a tertiary otology referral center, with 
data collected from our department's data base. Written informed consent was obtained from 
all of the eligible patients, and they were asked to score symptoms in a Measure of Perceived 
Stress (MPS) questionnaire (Brajac, 2003). Inclusion criteria were patients od 18 years of age 
and older, a positive diagnosis of SSNHL within 4 weeks prior to starting steroid therapy, 
completed corticosteroid treatment protocol, complete follow-up during the first month after 
steroid treatment and complete documentation and questionnaires. A total of 73 patients with 
SSNHL were enrolled in this study. MPS scale measures emotional, behavioral, and cognitive 
aspects of distress. Our scale modification consisted of 48 statements with which patients 
indicated their perceived stress on a 5-point Likert-type scale. The scale was validated in the 
Croatian language on a sample of 165 healthy adults and previously validated to be correlated 
to biological markers of stress (Brajac, 2003, Walvekar, 2015). In order to stratify patients 
according to the severity of stress level we performed a cluster analysis using a two-step 
cluster test. Two-step cluster analysis was performed to reveal natural groupings (or clusters) 
within our dataset that would otherwise not be apparent. The algorithm employed by this 
procedure has several desirable features that differentiate it from traditional clustering 
techniques; A) It can handle categorical and continuous variables: by assuming variables to be 
independent, a joint multinomial-normal distribution can be placed on categorical and 
continuous variables. B) Automatic selection of number of clusters: by comparing the values 
of a model-choice criterion across different clustering solutions, the procedure can 
automatically determine the optimal number of clusters. We used MPS scores as continuous 
6 
 
variables, and gender and stress class as categorical variables (high vs. low stress, above and 
below than median of the whole population). We excluded patients that had previous 
stapedectomy surgery, acoustic neurinoma, Meniere disease, patients receiving chemotherapy, 
and patients with psychiatric diagnoses in their medical history (4 patients post stapedectomy, 
5 patients with Meniere disease, 9 patients were diagnosed more than 4 weeks prior to 
treatment start). All of the patients met the criteria of sudden hearing loss: sudden onset of 
sensorineural hearing loss, unknown cause of hearing loss, average hearing level greater of 30 
dB at 500, 1000, 2000, 4000 and 8000 Hz. Pure tone audiometry (PTA) average was 
measured on the same day that patients started steroid therapy and on the day they completed 
their treatment. Patients received steroids (240 mg of intravenous methylprednisolone sodium 
succinate (Solu-Medrol, Pfizer Manufacturing, Belgium) for two days with tapering the dose 
down every 2 days until reaching 80 mg, and then continuing with oral steroid therapy for six 
days). The improvement in PTA was regarded as being significant if an average ≥15 dB shift 
in PTA was recorded when averaging PTA shifts at 500, 1000, 2000, 4000 and 8000 Hz. Pre-
treatment PTA levels were used to match patients from all three clusters, and then used the 
average improvement in PTA at 500, 1000, 2000, 4000 and 8000 Hz >15 dB as a cut-off level 
to designate whether the patient improved or not. We used this cut-off value to form a 
categorical variable of 0/1, that was used as a dependent variable in analyzing the differences 
in improvement levels between the clusters, alongside the average PTA improvement on all 
frequencies in dB. Using both variables added to the strength of our analysis, and used both 
the Kruskal-Wallis test and Friedman’s test used presented identical results. 
In order to exclude the impact of baseline hearing loss on the outcomes after treatment 
(hypothesizing that greater loss at baseline is more likely to have greater improvement in dB 
after treatment), a matched pair analysis according to baseline hearing loss was performed. 
Each patient in the moderate stress cluster was attributed a matched pair from the mild stress 
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cluster and from the severe stress cluster, which have identical or similar baseline hearing 
loss. This created a subset of 30 participants included in the secondary analysis using the 
Friedman’s test. 
The study was approved by the Ethics Committee of University Hospital “Sestre 
milosrdnice,” Zagreb School of Medicine and School of Dentistry. Patient characteristics that 
were analyzed with regard to hearing recovery were: presence of vertigo, age in years, 
duration between initial hearing loss and initiation of treatment, hearing loss patterns on pure 
tone audiogram and hearing loss severity. We also evaluated gender as a possible prognostic 
factor since cellular and molecular sex differences in stress response have been reported. 
Other tests, such as tympanometry, acoustic reflex and otoacoustic emission tests were not 
analyzed in this study. 
The data distribution was calculated using the Kolmogorov–Smirnov test. Internal consistency 
was measured with Cronbach’s alpha, a statistic calculated from the pairwise correlations 
between items used to measure the reliability of our psychometric test – the MPS score, 
confirming that the questions were not redundant. Statistical analysis was performed 
depending on the normality of the distribution using the Kruskal-Wallis test to compare 
outcomes between clusters with post-hoc analysis with Wilcoxon signed rank test, and Mann–
Whitney U two-tailed tests for unpaired comparisons. The patients between clusters were 
matched according to their pre-treatment PTA hearing loss levels, so that every moderate 
stress cluster patient was paired with a patient from the mild and severe stress patient cluster. 
Friedman test for paired samples was then performed to assess correlations (the non-
parametric alternative to the one-way ANOVA with repeated measures). All tests of statistical 
significance were performed using a two-sided 5% type I error rate.  
Statistical analysis was performed using MedCalc software (Version 11.2.1 © 1993-2010. 
MedCalc Software bvba Software, Broekstraat 52, 9030 Mariakerke, Belgium), and SPSS 
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(Version 22.0., 2013. IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp.) using 
standard descriptive statistics and frequency tabulation as indicated.  
Results 
 
The patient demographics are displayed in Table 1. Pure tone hearing level thresholds before 
and after steroid therapy were measured and the differences were correlated with patient data. 
There were 30 patients (55%) that showed significant improvement in their PTA hearing 
threshold average (≥15 dB). Three clusters according to stress levels were identified with 
good separation and a silhouette measure of cohesion and separation >0.65. Predictor 
importance of MPS scores was 0.6, indicating high relative importance of each predictor in 
estimating the reliability of each predictor in making a clustering prediction. The two-step 
cluster method included MPS scores and patient gender, as it is known that gender is a 
possible confounding variable in perceived stress scores (female patients have higher stress 
level at baseline).  
The cluster analysis divided patients into 3 clusters, according to MPS stress level scores 
(low, intermediate and high) and gender. The moderate stress cluster differed significantly in 
both variables from the other two; it had 10 patients (18.2%), with an average PTA hearing 
recovery of 43.8 dB and an average MPS score of 43.8 (moderate stress). The mild stress 
cluster encompassed 28 patients (50.9%) and showed an average PTA hearing recovery of 
6.39 dB, with an average MPS score of 31.46 (mild stress). The severe stress cluster had 17 
patients (30.9%), showed an average PTA hearing recovery of 8.18 dB, and an average MPS 
score of 94.94 (severe stress). 
There are several questions dealing with vertigo symptoms in the MPS questionnaire, and we 
analyzed its possible impact by designating a categorical variable to it in our data analysis – 
0/1, and then performed the Kruskal-Wallis test to see whether it had any impact on cluster 
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formation and whether it could impact the overall MPS scores unevenly among the clusters. It 
did not prove to be statistically significant, so we ruled it out as a possible confounding factor 
(Kruskal-Wallis test, χ2 = 2.97, df=1, P=0.294). Vertigo did not increase stress levels on the 
MPS scale. The recovery rate in the group of patients with vertigo did not differ significantly 
from patients without vertigo. We performed Mann-Whitney’s U test to see whether age 
could be a confounding factor, but its distribution was not significantly correlated to hearing 
recovery in our sample (P=906) and there was no significant age difference between the 
clusters (P=0.436).  
Prior to therapy, there were no significant differences in average PTA hearing loss thresholds 
between patients with severe and mild stress. The cluster with moderate stress had a 
significantly higher hearing loss at 500, 1000 and 2000 Hz, but not at 4000 and 8000 Hz 
(Kruskal-Wallis test, df =2, χ2 = 7.375, P=0.025 for 500 Hz, χ2=7.565, P=0.023 for 1000 Hz, 
χ2 = 3.090, P=0.213 for 4000 Hz, χ2 = 0.316, P=0.854 for 8000 Hz). Hearing level 
improvement was measured in all groups but only the patients with moderate stress the 
hearing improvement showed significant improvement.  
To avoid test-retest variability, we used a ≥15 dB PTA post-treatment threshold shift as a cut-
off value, and performed a ROC curve analysis of PTA pre-treatment and post-treatment 
shifts on 500, 1000, 2000, 4000 and 8000 Hz, and on the average PTA shift on all 
frequencies. The analysis showed AUC (area under curve) of 0.999, P<0.0001, and a cut-off 
value of 5 dB (Youden J index) with a 100% sensitivity and 96% specificity. 
When analyzing hearing recovery as a categorical variable, using the ≥15 dB post-treatment 
PTA threshold as a cut-off value, patients with moderate stress levels respond significantly 
better to treatment (Kruskal-Wallis test, χ2 = 20.407, df =2, P<0.001, Figure 1). The 
difference between pre-treatment and post-treatment hearing levels was significantly higher in 
the cluster with moderate stress compared to clusters with mild and high stress levels 
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(Kruskal-Wallis test, χ2 = 20.407, df =2, P<0.001, Figure 2). There were no differences in 
hearing levels after steroid therapy between groups of patients with mild and severe stress. 
We then paired patients between cluster groups according to their basal level of hearing loss 
(prior to therapy), where we matched patients from all 3 clusters to have the closest possible 
level of basal hearing loss. Every moderate stress cluster patient was paired with a patient 
from the mild and severe stress patient cluster. We then performed Friedman’s test for paired 
samples with the average improvement in PTA after therapy designated as the dependent 
variable. The analysis showed that the cluster with moderate stress levels shows a 
significantly higher level of improvement compared to clusters with mild and severe stress 
levels (Friedman test, χ2 = 18, df =2, P<0.0001, Figure 3).  
 
Discussion 
 
Stress is a process of increased arousal with the primary biological function of maintaining 
homeostasis. Short-term stress with sufficient recovery is beneficial, whereas long-term stress 
exposure without sufficient recovery may lead to various detrimental health effects, in 
accordance to Arndt-Schultz law and Hans Selye’s stress syndrome theory (Arndt-Schultz, nd, 
Trune, 2010 Selye, 1936). Chronic stress is associated with a greater risk of diabetes, 
cardiovascular disease, autoimmune diseases and many other disorders (Trune, 2010). Several 
studies have shown links between psychosocial distress and vascular disorders, diabetes, 
increased blood clotting, and decreased fibrinolysis (Cohen, 2012, von Känel, 2001). During 
viral infections, patients with higher levels of chronic stress exhibit glucocorticoid receptor 
resistance and failure in inflammatory response downregulation (Nouwen, 2009, Toda, 2011). 
Prolonged activation of the HPA and sympathetic-adrenal medullary system axes, might elicit 
a counter response in stimulated lymphocytes and downregulate the expression and function 
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of glucocorticoid receptors, leading to functional glucocorticoid resistance (Miller, 2002). 
This has already been identified in pediatric asthma patients, where subjects who perceived 
greater stress were more resistant to hydrocortisone’s effects on cytokine expression and 
activation of eosinophils relative to asthmatic subjects reporting lower stress levels (Miller, 
2009). Previous research has suggested that it is imperative to have background information 
about the individual’s stress levels before administering glucocorticoid therapy (von Känel, 
2001). After long term restraint stress in rats, modulation of the expression of glucocorticoid 
receptor (GR) and hypoxia-inducible factor 1 alpha (Hif1a) genes was observed in auditory 
tissues (the inferior colliculus, spiral ganglion, and the organ of Corti) (Trune, 2001). Also, 
the expression of an outer hair cell marker prestin was significantly up-regulated. This animal 
experiment indicated that that 24-h stress induced transient hypersensitivity of the auditory 
system and modulated gene expression in a tissue-specific manner (Tahera, 2007, Curtis, 
2006). Additional studies in both primate and murine models link social status and chronic 
social stress to hypercortisolism and steroid resistance (Trune, 2001, Cohen, 2012, von Känel, 
2001). Although stress in humans has been considered as a factor in pathophysiological 
mechanisms of SSNHL, several other recent studies could not confirm a correlation between 
stress levels and hearing recovery following steroid therapy (Nouwen, 2009, Toda, 2011). 
However, depression, the most common stress-related disorder, was linked with sudden 
sensorineural hearing loss onset (Tahera, 2007).  
Steroids have been widely used for the treatment of hearing loss for more than 60 years, ever 
since the association between inner ear and systemic autoimmune diseases was first reported. 
Nowadays, steroids are still the most commonly used in SSNHL treatment although in most 
cases no autoimmune disorders can be diagnosed. In autoimmune disorders in mice, steroid 
therapy improves the stria vascularis function (Trune, 2010). Stria vascularis is an important 
part of the cochlea involved in ion homeostasis and its malfunction could be one of the 
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principal factors in SSNHL occurrence (Trune, 2010). The protective role of steroids against 
acoustic trauma has been previously demonstrated (Canlon, 2007). It was shown that 
intratympanal application of dexamethasone prior to noise exposure prevented hearing loss by 
restoring glucocorticoid receptor expression in guinea pigs (Heinrich, 2016). Steroids are used 
in many immune disorders and their major action in suppression of immune response is to 
switch off inflammatory genes for cytokines, chemokines, adhesion molecules, inflammatory, 
enzymes, and receptors. Their immunosuppressive effect is widely considered as the most 
likely explanation of positive effects in hearing recovery (Conlin, 2007, Stachler, 2012, 
Barnes, 2013).  
Many factors have been reported as possible prognostic factors for SSNHL: age, the presence 
of vertigo, the severity of hearing loss, the shape of PTA thresholds, and the time from 
symptoms to the initiation of treatment (Roh, 2017). A recent study in military veterans from 
Iraq and Afghanistan has shown that comorbid posttraumatic stress disorders and depression 
were significantly associated with increased rates of hearing loss, tinnitus, or both conditions 
together (Swan, 2017). Lifestyle stress can play a role in pathophysiological mechanisms of 
SSNHL (Caldirola, 2016). In a recent study, depression, the most common stress-related 
disorder, was considered a risk factor for sudden sensorineural hearing loss (Lin, 2016). There 
are other reports regarding psychological correlation with SSNHL (Ghiadoni, 2000, Mazurek, 
2010, Tahera, 2006). 
Recent studies found no correlation between the level of stress and hearing recovery 
following steroid therapy (Roh, 2017). Depression, the most common stress-related disorder, 
was the only factor associated with a worse response to steroid treatment. Patients with mild 
depression responded better to steroid treatment while patients with severe depression were 
marked as non-responders to steroid treatment. Our results showed that patients with 
moderate stress levels respond better to steroid therapy than patients with high or mild stress 
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levels. As previously stated, stress is often associated with other disorders, principally 
vascular that could explain why patients with high stress levels did not respond well to steroid 
treatment. Moderate exposure (e.g. exercise or testing) increases the secretion of stress 
hormones and results in favorable physiological adaptations (Tahera, 2006, Cohen, 2007). 
However, stimuli that cause mild and short stress episodes, or on the other hand prolonged 
exposure to high levels of detrimental stress, may lead to under or over activation of 
physiological adaptation mechanisms (Schmitt, 2000, Lopez-Gonazalez, 2009, Byl, 1984). 
This could explain why both patients with mild levels of stress and with high levels of stress 
did not respond well to steroid therapy.  
A hypothesis related to the difference in prevalence of stress associated diseases in females 
relies upon the gender-biased corticotropin-releasing factor subtype 1 receptor (CRF1) 
signaling pathway (McEwen, 2007). Conditions associated with chronic stress exposure are 
more common in females (Neuser, 1986, Saeki, 1994, Bangasser, 2014). Recent research of 
the interaction between chronic stress and severity of chronic rhinosinuitis (CRS) in a disease 
specific questionnaire, has shown significant association of CRS severity and chronic stress. 
(Tomljenovic, 2018). We, however, were unable to confirm these previously reported gender 
differences in stress induced inflammatory responses in this paper.  
We recognize that there are limitations of our study, principally regarding our sample size, 
despite the fact that high levels of statistical significance was demonstrated in our tests. 
Adjusting for confounding factors such as age, vertigo, and configuration of hearing loss was 
not entirely possible, but measures were taken to ensure that they do not influence the 
reproducibility of the results by pairing patients according to pre-treatment hearing loss and 
enforcing strict exclusion criteria. This is a single-center study, which also may add bias to 
patient selection. We cannot consider our analysis flawless, but would also point out that our 
data seem to indicate a significant interaction between hearing recovery and stress levels, 
14 
 
which support the Arndt-Schultz law elegantly, ecpecially when translated into Selye’s 
Syndrome - an expression of Claude Bernard’s milieu intérieur. (Selye, 1936). 
There is a clear clinical need to be able to predict which patients will benefit from steroid 
therapy. Our results suggest that patients with moderate stress levels show significantly better 
results after steroid treatment for sudden sensorineural hearing loss than patients with low or 
high stress levels. Unfavorable results in these patient groups may be explained by the 
detrimental effects of chronic stress exposure on physiological adaptive mechanisms of the 
auditory system.  
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Figures and Legends 
 
 
Figure 1. Patients with moderate stress levels respond significantly better to treatment when 
analyzed as a categorical variable (Kruskal-Wallis test, P<0.001, N=10, using the 
≥15 dB post-treatment PTA hearing threshold recovery as a cut-off value). 
 
Figure 2. Patients in the moderate stress cluster showed a significantly higher difference 
between pre-treatment and post-treatment hearing levels compared to clusters with 
mild and severe stress levels (Kruskal-Wallis test, P<0.001, N=55) 
 
Figure 3. Patients in the moderate stress level cluster showed statistically higher post-
treatment average PTA hearing recovery thresholds at all frequencies when matched 
to the patients in the other two clusters according to pre-treatment PTA hearing 
levels (Friedman test, P<0.0001, N=30). 
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Table 1. Patient demographics, MPS scores and post-treatment PTA shifts among the patient 
clusters 
 
 
Mild 
stress 
cluster 
Moderate 
stress 
cluster 
Severe 
stress 
cluster Total P value and test 
Number of patients 28 10 17 55  
Age (years) 49.25 44.6 53.5 50.54 Kruskal-Wallis test p>0.05 
Gender 
12 male, 
16 female 
patients 
5 male,  
5 female 
patients 
6 male,  
11 female 
patients 
23 male, 
22 female 
patients Kruskal-Wallis test p>0.05 
Vertigo present 8 patients 2 patients 5 patients  Kruskal-Wallis test p>0.05 
Average MPS score 31.46 43.8 94.94 56.1 Two-step cluster analysis 
Average post-treatement 
PTA shift on all 
frequencies 6.39 dB 43.8 dB 8.18 dB 14.6 dB 
Kruskal-Wallis test, χ2 = 
20.407, df =2, P<0.001, 
Friedman test, χ2 = 18, df 
=2, P<0.0001 
 
